IQ-101
An investigational reformulation of an approved drug for local delivery in secondary lymphoedema.
Candidate design
Now
Designing and characterising candidate formulations.
Next
Animal studies, then partnering.
Medicines for the lymphatic system.
Each medicine is designed by GyaniMed, our formulation model.
TARGET TISSUE / 01
Why the lymphatic system.
The lymphatic system is where adaptive immune responses begin, where many cancers spread and where lymphoedema starts.
THE MEDICINES / 02
Where each medicine stands.
TPF
Therapeutic Pathway Finder
A theranostic nanoparticle.
Design campaign
Now
Making the first candidate formulations.
Next
Imaging proof of concept in animals, then partnering.
VDF
Vaccine Delivery Finder
A vaccine carrier with fridge- or room-temperature stability as its design target.
Design campaign
Now
Designing candidate formulations and characterising their stability.
Next
A characterised set of candidate formulations.
LICENSING
License a medicine.
Write to us with the medicine and the territory you have in mind.
Partners with a candidate of their own can get in touch about a formulation programme.